{"title":"支持重新参与和持续参与艾滋病毒护理的研究框架。","authors":"Marie-Claude C Lavoie,Elvin H Geng","doi":"10.1016/s2352-3018(25)00190-0","DOIUrl":null,"url":null,"abstract":"Globally, in 2024, 87% of all people living with HIV knew their HIV status, and among people aware of their status and on treatment, 94% were virally suppressed. As progress is being made to reach the UNAIDS 95-95-95 targets, one of the key public health challenges for HIV lies in optimising continuity of care and effectively re-engaging people out of care. Across settings, up to 40-50% of individuals diagnosed with HIV are disengaged from HIV care. Delaying or discontinuing HIV treatment can negatively affect health outcomes at the individual level, including increasing viraemia and mortality, and increases the risk for ongoing HIV transmission at the community level. In addition to the scarcity of HIV research focusing on continuous retention and re-engagement, there are also methodological gaps interfering with our ability to better understand and intervene. This Viewpoint emphasises the importance of more nuanced distinctions of concepts related to disengagement and re-engagement, balancing data harmonisation with flexibility to facilitate evidence generation and collaboration, and identifying and testing re-engagement interventions. Developing a global research agenda, along with methodological guidance, would assist in moving synergistically and intentionally towards a comprehensive approach to re-engagement.","PeriodicalId":48725,"journal":{"name":"Lancet Hiv","volume":"62 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A research framework to support re-engagement and continuous engagement in HIV care.\",\"authors\":\"Marie-Claude C Lavoie,Elvin H Geng\",\"doi\":\"10.1016/s2352-3018(25)00190-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Globally, in 2024, 87% of all people living with HIV knew their HIV status, and among people aware of their status and on treatment, 94% were virally suppressed. As progress is being made to reach the UNAIDS 95-95-95 targets, one of the key public health challenges for HIV lies in optimising continuity of care and effectively re-engaging people out of care. Across settings, up to 40-50% of individuals diagnosed with HIV are disengaged from HIV care. Delaying or discontinuing HIV treatment can negatively affect health outcomes at the individual level, including increasing viraemia and mortality, and increases the risk for ongoing HIV transmission at the community level. In addition to the scarcity of HIV research focusing on continuous retention and re-engagement, there are also methodological gaps interfering with our ability to better understand and intervene. This Viewpoint emphasises the importance of more nuanced distinctions of concepts related to disengagement and re-engagement, balancing data harmonisation with flexibility to facilitate evidence generation and collaboration, and identifying and testing re-engagement interventions. Developing a global research agenda, along with methodological guidance, would assist in moving synergistically and intentionally towards a comprehensive approach to re-engagement.\",\"PeriodicalId\":48725,\"journal\":{\"name\":\"Lancet Hiv\",\"volume\":\"62 1\",\"pages\":\"\"},\"PeriodicalIF\":13.0000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Hiv\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s2352-3018(25)00190-0\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Hiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2352-3018(25)00190-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
A research framework to support re-engagement and continuous engagement in HIV care.
Globally, in 2024, 87% of all people living with HIV knew their HIV status, and among people aware of their status and on treatment, 94% were virally suppressed. As progress is being made to reach the UNAIDS 95-95-95 targets, one of the key public health challenges for HIV lies in optimising continuity of care and effectively re-engaging people out of care. Across settings, up to 40-50% of individuals diagnosed with HIV are disengaged from HIV care. Delaying or discontinuing HIV treatment can negatively affect health outcomes at the individual level, including increasing viraemia and mortality, and increases the risk for ongoing HIV transmission at the community level. In addition to the scarcity of HIV research focusing on continuous retention and re-engagement, there are also methodological gaps interfering with our ability to better understand and intervene. This Viewpoint emphasises the importance of more nuanced distinctions of concepts related to disengagement and re-engagement, balancing data harmonisation with flexibility to facilitate evidence generation and collaboration, and identifying and testing re-engagement interventions. Developing a global research agenda, along with methodological guidance, would assist in moving synergistically and intentionally towards a comprehensive approach to re-engagement.
期刊介绍:
The Lancet HIV is an internationally trusted source of clinical, public health, and global health knowledge with an Impact Factor of 16.1. It is dedicated to publishing original research, evidence-based reviews, and insightful features that advocate for change in or illuminates HIV clinical practice. The journal aims to provide a holistic view of the pandemic, covering clinical, epidemiological, and operational disciplines. It publishes content on innovative treatments and the biological research behind them, novel methods of service delivery, and new approaches to confronting HIV/AIDS worldwide. The Lancet HIV publishes various types of content including articles, reviews, comments, correspondences, and viewpoints. It also publishes series that aim to shape and drive positive change in clinical practice and health policy in areas of need in HIV. The journal is indexed by several abstracting and indexing services, including Crossref, Embase, Essential Science Indicators, MEDLINE, PubMed, SCIE and Scopus.